AN ACT ESTABLISHING AN ADVISORY COUNCIL ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY AND OTHER GENE THERAPIES.
FILE NO. 566
Email me when SB 451 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 451. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would form an advisory council within the Department of Public Health to recommend policies on the availability, cost, training, safety, and outcomes of CAR‑T and other gene therapies for cancer patients. It would bring together state officials, clinicians, industry experts, patient advocates and caregivers to advise the health department and report to the legislature. The goal is to improve equitable, financially sustainable access to these advanced therapies.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 451
3 free questions a day, no accountHearings
- Public Health Committee Meeting (1D-ZOOM)Public Health Committee · Mar 23, 2026
- Public Health Committee Public Hearing (1D-ZOOM)Public Health Committee · Mar 13, 2026
History
- SENATE CALENDAR NUMBER 332
- RPTD. OUT OF LCO
- FILE NO. 566
- FAV. RPT., TAB. FOR CAL., SEN.
- REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 04/08/26
- FILED WITH LCO
- Joint Favorable
- PUBLIC HEARING 0313
- REF. TO JOINT COMM. ON Public Health
Sponsors
- Martha Marx (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 451 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 451 freeOr ask your AI assistant about SB 451 directly:
Add to Claude, ChatGPT or Cursor